Nothing Special   »   [go: up one dir, main page]

JPH07275354A - Drug dissolving device - Google Patents

Drug dissolving device

Info

Publication number
JPH07275354A
JPH07275354A JP6108887A JP10888794A JPH07275354A JP H07275354 A JPH07275354 A JP H07275354A JP 6108887 A JP6108887 A JP 6108887A JP 10888794 A JP10888794 A JP 10888794A JP H07275354 A JPH07275354 A JP H07275354A
Authority
JP
Japan
Prior art keywords
solution
concentration
drug
dissolution
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6108887A
Other languages
Japanese (ja)
Inventor
Takeshi Shibata
猛 柴田
Toshio Gotsu
利雄 五津
Yoshihiro Zokuma
由広 続麻
Hiroyuki Suzuki
博之 鈴木
Toshiyuki Nakama
敏之 中間
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toa Electronics Ltd
Scitec KK
Original Assignee
Toa Electronics Ltd
Scitec KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toa Electronics Ltd, Scitec KK filed Critical Toa Electronics Ltd
Priority to JP6108887A priority Critical patent/JPH07275354A/en
Publication of JPH07275354A publication Critical patent/JPH07275354A/en
Pending legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)

Abstract

PURPOSE:To provide a device which automatically makes medical fluid for a blood dialyser from powder drug using an electrical conductivity meter as a detector for the concentration of solution. CONSTITUTION:Powder drug is supplied from a dissolving water and drug A supplier 3 to a dissolving section 4, the temperature of solution is maintained at above 20 deg.C with a heater 2, the concentration of the solution is continuously detected by a concentration detector 1, the supplying amount of the powder drug is controlled, and a specified concentration of medical fluid is obtained.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】この発明は、腎不全等の治療に使
用される血液透折装置に供給するための薬液を、容易に
かつ効率良く調製する薬剤溶解装置にかかるものであ
る。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a drug dissolving device for easily and efficiently preparing a drug solution to be supplied to a blood transfusion device used for treating renal failure or the like.

【0002】[0002]

【従来の技術】血液透析用薬液には、塩化ナトリウム系
溶液(以下A液と呼ぶ)及び重炭酸ナトリウム系溶液
(以下B液と呼ぶ)が使用されている。これらの溶液
は、治療上の必要性から所定の濃度に対し、濃度差±1
%程度に管理されている。通常、A液はA原液(A剤の
濃厚溶液)を希釈し、B液はB原液(主として重炭酸ナ
トリウムの濃厚溶液)を希釈して調製するが、これらの
原液は濃度を正しく管理しなければならないので、薬品
メーカーが調製し、A原液、B原液とも10l容器入り
として販売している。血液透析装置への薬液の供給は、 (イ)A原液、B原液とも薬品メーカーから購入する。 (ロ)A原液は薬品メーカーから購入する。 B原液は、200l位の大容量のタンクに溶解用水を満
たし、撹拌装置で撹拌しつつ、人手によるサンプリング
並びに浸透圧計による濃度測定を行い、重炭酸ナトリウ
ムを主成分とする粉末薬剤(以下B剤と呼ぶ)の供給量
を加減して、所定の濃度のB原液を調製する。これらの
原液を血液透析装置へ供給するのは有資格者の手によっ
て行われる。
2. Description of the Related Art Sodium chloride type solutions (hereinafter referred to as solution A) and sodium bicarbonate type solutions (hereinafter referred to as solution B) are used as hemodialysis chemicals. These solutions have a concentration difference of ± 1 with respect to a given concentration due to therapeutic needs.
It is managed to about%. Solution A is usually prepared by diluting stock solution A (concentrated solution of agent A) and solution B is prepared by diluting solution B (mainly concentrated solution of sodium bicarbonate), but these stock solutions must be properly controlled in concentration. Since it has to be prepared, it is prepared by a drug manufacturer and sold as 10 liter containers for both A stock solution and B stock solution. To supply the drug solution to the hemodialysis machine, (a) Purchase both the A stock solution and the B stock solution from the drug manufacturer. (B) A stock solution is purchased from a chemical manufacturer. The stock solution B is filled with water for dissolution in a large-capacity tank of about 200 liters, and while being stirred by a stirrer, manually sampled and measured the concentration by an osmometer, and is a powdered drug containing sodium bicarbonate as a main component (hereinafter referred to as agent B (Referred to as “)” is adjusted to prepare a stock solution B having a predetermined concentration. Supplying these stock solutions to the hemodialysis machine is done by a qualified person.

【0003】[0003]

【発明が解決しようとする課題】1人分の血液透析には
A原液及びB原液各5lを必要とする。よって薬品メー
カーから購入するA原液及びB原液の10l容器入りは
2人分の量である。血液透析の需要は極めて多く、使用
する薬液の量も膨大となり、A原液(上記(イ)の場合
はB原液も)の購入量が多くなるだけでなく、血液透析
装置への薬液供給にも可成の労力を要する。以上のよう
に、従来行われている血液透析装置への薬液供給は、増
大する透析の需要に対処すべく、省力化、効率化が不可
欠である。
5 liters of A stock solution and 5 B stock solution are required for hemodialysis for one person. Therefore, the amount of A stock solution and B stock solution purchased from a drug manufacturer in a 10-liter container is equivalent to two people. Demand for hemodialysis is extremely high, and the amount of drug solution used is enormous. Not only does A stock solution (and B stock solution in the case of (a) above) be purchased in large quantities, but it is also used to supply the drug solution to the hemodialysis machine. It takes a lot of effort. As described above, in the conventional chemical solution supply to the hemodialysis device, labor saving and efficiency improvement are indispensable in order to meet the increasing demand for dialysis.

【0004】[0004]

【課題を解決するための手段】この発明の構成を説明す
ると、 (イ)溶解用水(逆浸透膜ろ過水等)を供給する手段を
備える。 (ロ)電気伝導率計による溶液の濃度検出部を設ける。 (ハ)溶解用水又は溶液を加温する加温部を設ける。 (ニ)粉末薬剤の供給量を制御できるA剤供給部を設け
る。 (ホ)粉末薬剤の溶解部を設ける。 (ヘ)薬液の取出口を設ける。 以上により構成する。
The structure of the present invention will be described. (A) Means for supplying dissolution water (reverse osmosis membrane filtered water, etc.) is provided. (B) Provide a solution concentration detection unit using an electric conductivity meter. (C) A heating unit for heating the water or solution for dissolution is provided. (D) An A-agent supply unit that can control the supply amount of the powdered medicine is provided. (E) A dissolving part for the powdered medicine is provided. (F) Provide a chemical solution outlet. It is configured as described above.

【0005】[0005]

【作用】次に本発明の作用を説明する。薬液の調製は、
基本的には、溶解用水を溶解槽等に入れ、これに粉末薬
剤を供給して溶解させ、溶液濃度を調整して行う。本発
明にかかる薬剤溶解装置は、これらの操作を自動的にか
つ連続的に行うため、溶解用水を溶解部に導入し、溶液
濃度を所定の濃度に調整するため、溶液濃度を検出しつ
つ、粉末薬剤の供給量を制御して溶解部に供給するよう
に作動する。溶液の濃度検出手段に使用する電気伝導率
計による溶液濃度の検出原理は、電気伝導率が溶液濃度
により異なることを利用している。電気伝導率と溶液濃
度の関係は、溶液中に溶解している物質により異なる
が、上記のA剤の溶液を例に説明する。A剤の溶液の電
気伝導率は、主成分である塩化ナトリウム溶液の電気伝
導率とほぼ一致する。また、この電気伝導率は溶液温度
によって異なる。図1は塩化ナトリウム溶液の濃度に対
する電気伝導率を、温度別に示したグラフ(横浜国立大
学吉田梅次郎著電子と化学計測より)である。縦軸に電
気伝導率を、横軸に溶液濃度を重量%で表わし、温度別
の曲線として関係を表わしている。図1より、溶液温度
が高い方が溶液の濃度変化に対する電気伝導率の変化が
大きいことが分かる。これは溶液温度が高い方が、電気
伝導率計による溶液濃度の検出感度が高く、溶液濃度の
微小差も電気伝導率の変化として検出できることを示し
ている。これは薬液の濃度を精度良く調製するために必
要な条件である。電気伝導率計の溶液濃度検出感度を高
くするためには、溶解部の溶液温度を高くすることが必
要で、溶解用水を加温するか、溶解部の溶液を加温する
など、溶液温度を適当な温度範囲(例えば20℃以上)
に保つようにする。このようにして、溶液濃度の微小差
を検出できる手段を講じ、所定の溶液濃度になるように
粉末薬剤の供給量を制御することにより、濃度精度の良
い薬液を調製することができる。粉末薬剤の供給量を制
御する代わりに、溶解用水の供給量を制御しても、また
両方を制御しても差し支えない。
Next, the operation of the present invention will be described. The preparation of the drug solution is
Basically, the water for dissolution is put in a dissolution tank or the like, and the powdered medicine is supplied and dissolved therein, and the solution concentration is adjusted. The drug dissolution apparatus according to the present invention, in order to perform these operations automatically and continuously, introduces water for dissolution into the dissolution section and adjusts the solution concentration to a predetermined concentration, while detecting the solution concentration, It operates so as to control the supply amount of the powdered medicine and supply it to the dissolution section. The principle of detecting the solution concentration by the electric conductivity meter used as the solution concentration detecting means utilizes that the electric conductivity varies depending on the solution concentration. The relationship between the electrical conductivity and the solution concentration depends on the substance dissolved in the solution, but the solution of the above-mentioned agent A will be described as an example. The electric conductivity of the solution of the agent A is almost the same as the electric conductivity of the sodium chloride solution which is the main component. Further, this electric conductivity varies depending on the solution temperature. FIG. 1 is a graph showing the electric conductivity with respect to the concentration of the sodium chloride solution for each temperature (from Umejiro Yoshida, Yokohama National University, electron and chemical measurement). The vertical axis represents the electric conductivity, the horizontal axis represents the solution concentration in weight%, and the relationship is represented as a curve for each temperature. It can be seen from FIG. 1 that the higher the solution temperature, the greater the change in the electrical conductivity with respect to the change in the concentration of the solution. This shows that the higher the solution temperature, the higher the sensitivity of the solution concentration detection by the electric conductivity meter, and the minute difference in the solution concentration can be detected as a change in the electric conductivity. This is a condition necessary for accurately adjusting the concentration of the drug solution. In order to increase the solution concentration detection sensitivity of the electric conductivity meter, it is necessary to raise the temperature of the solution in the dissolution section.The solution temperature must be raised by heating the water for dissolution or by heating the solution in the dissolution section. Appropriate temperature range (for example, 20 ℃ or higher)
Try to keep In this way, by providing a means capable of detecting a minute difference in the solution concentration and controlling the supply amount of the powdered drug so that the solution has a predetermined solution concentration, it is possible to prepare a drug solution having a high concentration accuracy. Instead of controlling the supply amount of the powder drug, it is possible to control the supply amount of the dissolving water or both.

【0006】[0006]

【実施例】本発明の実施例を説明する。図2は本発明の
1実施例のブロック図である。図2に示す実施例は、溶
解用水を加温部において、例えば約30℃に加温して溶
解部に供給し、濃度検出部で溶液の濃度を検出しつつ、
A剤の供給量を制御して、所定濃度のA液(又はA原
液)を調製する例である。図3は本発明の他の実施例の
フロー図である。図3の実施例は溶解部の溶液を連続的
に加温部を通して循環し、例えば約25℃に加温しつつ
A剤を溶解し、図2に示す実施例同様、濃度検出部で溶
液の濃度を検出しつつA剤の供給量を制御して、所定濃
度のA液(又はA原液)を調製する例である。
EXAMPLES Examples of the present invention will be described. FIG. 2 is a block diagram of one embodiment of the present invention. In the embodiment shown in FIG. 2, the dissolution water is heated in the heating unit, for example, to about 30 ° C. and supplied to the dissolution unit, and the concentration detection unit detects the concentration of the solution,
This is an example in which the supply amount of the agent A is controlled to prepare the solution A (or the stock solution A) having a predetermined concentration. FIG. 3 is a flow chart of another embodiment of the present invention. In the embodiment of FIG. 3, the solution in the dissolution section is continuously circulated through the heating section, and the agent A is dissolved while being heated to, for example, about 25 ° C. As in the embodiment shown in FIG. This is an example of controlling the supply amount of the agent A while detecting the concentration to prepare the solution A (or the stock solution A) having a predetermined concentration.

【0007】[0007]

【発明の効果】本発明の薬剤溶解装置により、A液(又
はA原液)を調製した時の溶液濃度差は±1%以内、B
液(又はB原液)を調製した時の溶液濃度差は±0.7
%程度にできる。また、本発明にかかる薬剤溶解装置を
使用することにより、薬液の連続調製が可能になり調製
能力も大きくなる。
EFFECT OF THE INVENTION When the solution A (or stock solution A) is prepared by the drug dissolving apparatus of the present invention, the difference in solution concentration is within ± 1%,
Solution concentration difference when the solution (or B stock solution) was prepared is ± 0.7
It can be about%. Further, by using the drug dissolving device according to the present invention, it is possible to continuously prepare a drug solution, and the preparation capacity is increased.

【図面の簡単な説明】[Brief description of drawings]

【図1】塩化ナトリウム溶液の濃度に対する電気伝導率
を示すグラフ
FIG. 1 is a graph showing the electric conductivity with respect to the concentration of a sodium chloride solution.

【図2】本発明の1実施例のブロック図FIG. 2 is a block diagram of an embodiment of the present invention.

【図3】本発明の他の実施例のフロー図FIG. 3 is a flowchart of another embodiment of the present invention.

【符号の説明】[Explanation of symbols]

1 濃度検出部 2 加温部 3 A剤供給部 4 溶解部 5 供給量制御弁 6 開閉弁 7 送液ポンプ 8 電気伝導率検出器 9 薬液取出弁 1 Concentration detection part 2 Heating part 3 A agent supply part 4 Melting part 5 Supply amount control valve 6 Open / close valve 7 Liquid feed pump 8 Electrical conductivity detector 9 Chemical liquid take-out valve

───────────────────────────────────────────────────── フロントページの続き (72)発明者 続麻 由広 埼玉県狭山市大字北入曽613番地 東亜電 波工業株式会社狭山工場内 (72)発明者 鈴木 博之 埼玉県狭山市大字北入曽613番地 東亜電 波工業株式会社狭山工場内 (72)発明者 中間 敏之 埼玉県狭山市大字北入曽613番地 東亜電 波工業株式会社狭山工場内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Yasuhiro Yuma, 613 Kitairizo, Sayama City, Saitama Prefecture Toa Denwa Kogyo Co., Ltd. Sayama Plant (72) Hiroyuki Suzuki, 613 Kitaiso, Sayama City, Saitama Prefecture Toa Denwa Kogyo Co., Ltd. Sayama Plant (72) Inventor Toshiyuki Naka, 613 Kitairizo, Sayama City, Saitama Prefecture Toa Denwa Kogyo Co., Ltd. Sayama Plant

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 血液透析用薬液の調製に際し、塩化ナト
リウムを主成分とする粉末薬剤(以下A剤と呼ぶ)を溶
解用水に溶解する工程において、A剤の供給量を制御す
ることにより所定の溶液濃度に調製すべく、溶液の濃度
検出手段として電気伝導率計を使用し、かつ溶液温度を
20℃以上に保つことを特徴とする薬剤溶解装置。
1. When a hemodialysis drug solution is prepared, a predetermined amount is controlled by controlling the supply amount of the agent A in the step of dissolving a powdered drug containing sodium chloride as a main component (hereinafter referred to as agent A) in water for dissolution. A drug dissolving device characterized in that an electric conductivity meter is used as a solution concentration detecting means to adjust the solution concentration, and the solution temperature is kept at 20 ° C. or higher.
JP6108887A 1994-04-13 1994-04-13 Drug dissolving device Pending JPH07275354A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6108887A JPH07275354A (en) 1994-04-13 1994-04-13 Drug dissolving device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6108887A JPH07275354A (en) 1994-04-13 1994-04-13 Drug dissolving device

Publications (1)

Publication Number Publication Date
JPH07275354A true JPH07275354A (en) 1995-10-24

Family

ID=14496122

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6108887A Pending JPH07275354A (en) 1994-04-13 1994-04-13 Drug dissolving device

Country Status (1)

Country Link
JP (1) JPH07275354A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007117396A (en) * 2005-10-27 2007-05-17 Dkk Toa Corp Apparatus for dissolving medical agent
JP2007117886A (en) * 2005-10-27 2007-05-17 Dkk Toa Corp Chemical dissolving device
JP2009528631A (en) * 2006-03-01 2009-08-06 エンテグリース,インコーポレイテッド System and method for controlled fluid mixing and setpoint multiplexing
JP5099464B1 (en) * 2011-12-29 2012-12-19 富田製薬株式会社 Bicarbonate ion concentration-variable dialysate preparation device and preparation method, bicarbonate ion concentration-variable dialysate, and bicarbonate ion concentration-variable dialyzing system
WO2016125902A1 (en) * 2015-02-06 2016-08-11 旭化成メディカル株式会社 Treatment solution preparation device and blood processing system

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007117396A (en) * 2005-10-27 2007-05-17 Dkk Toa Corp Apparatus for dissolving medical agent
JP2007117886A (en) * 2005-10-27 2007-05-17 Dkk Toa Corp Chemical dissolving device
JP4653630B2 (en) * 2005-10-27 2011-03-16 東亜ディーケーケー株式会社 Drug dissolving device
JP2009528631A (en) * 2006-03-01 2009-08-06 エンテグリース,インコーポレイテッド System and method for controlled fluid mixing and setpoint multiplexing
JP5099464B1 (en) * 2011-12-29 2012-12-19 富田製薬株式会社 Bicarbonate ion concentration-variable dialysate preparation device and preparation method, bicarbonate ion concentration-variable dialysate, and bicarbonate ion concentration-variable dialyzing system
JP2013150767A (en) * 2011-12-29 2013-08-08 Tomita Pharmaceutical Co Ltd Preparation apparatus and preparation method for dialysis fluid of variable bicarbonate ion concentration type, dialysate of variable bicarbonate ion concentration type, and dialysis system of variable bicarbonate ion concentration type
WO2016125902A1 (en) * 2015-02-06 2016-08-11 旭化成メディカル株式会社 Treatment solution preparation device and blood processing system
JPWO2016125902A1 (en) * 2015-02-06 2017-09-14 旭化成メディカル株式会社 Treatment liquid preparation device and blood treatment system
CN107206142A (en) * 2015-02-06 2017-09-26 旭化成医疗株式会社 Treat liquid producing device and blood processing system
CN107206142B (en) * 2015-02-06 2019-08-09 旭化成医疗株式会社 Treat liquid producing device and blood processing system

Similar Documents

Publication Publication Date Title
JP7559129B2 (en) Fluid preparation and treatment devices, methods, and systems
US6755976B2 (en) Safety arrangement for a dialysis machine and method of activating the safety arrangement
US3508656A (en) Portable dialysate supply system
JPH06125983A (en) System controls medical treating device
JP4059933B2 (en) Method and apparatus for centrally producing a salt concentrate, method for disinfecting containers intended for said apparatus and apparatus
US6280634B1 (en) Method of determining system volume of a dialysis machine
JPS63194666A (en) System for adjusting fluid for medical treatment and cartridge used therein
US4711715A (en) Apparatus for extracorporeal treatment of blood
JPH11313885A (en) Dialyzed patient's blood parameter determining method and device therefor
JPH06504708A (en) Hemodialysis conductivity servo proportional compounding system
JPS61279251A (en) Dialysis control system
JP2008526375A (en) Purification system for solution preparation for medical applications
WO2001095954A1 (en) Dialyzate solution preparing device
US9731059B2 (en) Sensor and method of sensing for dialysis machine
JPH07275354A (en) Drug dissolving device
JP2000107281A (en) Roller pump and blood treating circuit
CN201342127Y (en) Online peritoneum dialysis apparatus
JP4653630B2 (en) Drug dissolving device
JP4359510B2 (en) Production of dialysis concentrate from high-density concentrate precursor and equipment used in dialysis site
CN101745157A (en) Online peritoneal dialysis unit and preparation method
US10987458B2 (en) Method of using a medical fluid generating machine
CN108498889A (en) The online compounding and controlling system of dialysis machine working solution and dialysis machine
CN112843362A (en) Dialysate preparation and supply device for dialysate system
CN112618828A (en) Dialysis machine
JP2000245825A (en) Dialysis liquid preparation apparatus